Sa1063 Long-Term Efficacy of Sacral Nerve Stimulation for Treating Slow Transit Constipation

Abstract

12.9%; diagnosed 2001-2004 vs. diagnosed 2005 or later). For those subjects diagnosed after 2005, 77.7% and 68.7% are still using IFX at 6 and 12months respectively. Conclusions: Despite being available for almost a decade, use of biologic agents across the population for IBD is very low. However, they are being used with greater frequency and earlier in the course of disease. Further study is required to determine if this low rate of use is appropriate or whether these medications are being underutilized in the community